Videos and Media

Two new studies came out showing the Epstein-Barr virus (EBV) may be “the cause” of MS. Q&A with Dr. Katz.

This is a very interesting study. We always knew Epstein-Barr virus was an important risk factor for MS. Now it appears it may actually directly cause MS! What does this mean? Perhaps this could lead to more targeted treatments and prevention! Read the full article in the January 2022 issue of Science, here.

Q&A with Dr. Katz. On New Year’s Eve 2021, Dr. Katz conducted a virtual Q&A session on the topic of COVID-19 to discuss recommendations for monoclonal antibody treatments, boosters, and what might be coming in the next few weeks and months.

Confused about insurance? Health insurance and financial assistance can be complicated. Marissa Shackleton spoke with the Siegel Rare Neuroimmune Association on Friday to explain insurance and access to care. Marissa answers questions such as: What are insurance benefits? Who is eligible for medicare and medicaid? What is open enrollment? How can I get assistance to…

We’re pleased to announce that our paper, “Humoral and T-Cell Responses to SARS-CoV-2 Vaccination in Multiple Sclerosis Patients Treated with Ocrelizumab” was published today! We’re extremely proud and grateful to all of you who participated! Your contributions added to our scientific knowledge and understanding! Read the full article here.

The ELC research team presented at the annual The Consortium of Multiple Sclerosis Centers this week. ELC treated the first patient with commercial Ocrevus nationwide in 2017 and has been collecting data on Ocrevus patients in “ACAPELLA” ever since. The team presents data on ACAPELLA at CMSC and ECTRIMS annually. NeurologyLive highlighted ACAPELLA: Real-World Experience…

Thank you NICA – National Infusion Center Association for spotlighting our center and infusion suite! Our infusion suite is conveniently located within the multiple sclerosis center for streamlined care. Our physicians are on-site, our infusion nurses are multiple sclerosis certified and our infusion coordinator is an expert at navigating insurance and financial assistance!

Dr. Katz was interviewed by NeurologyLive discussing COVID-19 boosters for patients with multiple sclerosis.  “The good news for MS patients is that for the most part, they don’t appear to be more susceptible to getting COVID, or having more severe infections if they do get COVID… But we don’t really have a lot of experience…

In August 2021, Dr. Katz presented a Q&A virtual session on the topic of the timing of COVID-19 booster vaccines for MS patients on Ocrevus. View the recorded video below or on our Facebook page.

On May 14, 2021, Dr. Katz sat down for a virtual Q&A session to discuss updates on how MS patients have been responding to the coronavirus vaccines, and what to do. View the video below or on our Facebook page.